Karel Ulbrich Selected Research

Karel Ulbrich Research Topics

Disease

66	Neoplasms (Cancer) 07/2019 - 01/2003
8	Infections 11/2013 - 02/2008
7	T-Cell Lymphoma (Lymphoma, T Cell) 12/2012 - 10/2003
5	Carcinoma (Carcinomatosis) 11/2016 - 08/2002
3	Breast Neoplasms (Breast Cancer) 12/2018 - 08/2003
3	Prostatic Neoplasms (Prostate Cancer) 02/2016 - 07/2010
3	Leukemia 03/2013 - 05/2002
2	Colonic Neoplasms (Colon Cancer) 12/2018 - 11/2015
2	Melanoma (Melanoma, Malignant) 10/2011 - 10/2010
2	Ovarian Neoplasms (Ovarian Cancer) 03/2008 - 02/2008
1	Lung Neoplasms (Lung Cancer) 09/2018
1	Neuroblastoma 10/2016
1	Neoplasm Metastasis (Metastasis) 02/2016
1	Arthritis (Polyarthritis) 01/2014
1	Sarcoma (Soft Tissue Sarcoma) 02/2013
1	Kidney Neoplasms (Kidney Cancer) 10/2011
1	Bloom Syndrome 08/2011

Drug/Important Bio-Agent (IBA)

37	PolymersIBA 12/2018 - 09/2007
36	hydroxypropyl methacrylateIBA 01/2018 - 05/2002
24	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 08/2003
17	N-(2-hydroxypropyl)methacrylamideIBA 12/2016 - 08/2003
9	MicellesIBA 01/2018 - 10/2009
8	Drug CarriersIBA 01/2018 - 07/2009
6	pirarubicinIBA 12/2018 - 01/2014
6	methacrylamideIBA 01/2018 - 10/2009
6	Cytostatic AgentsIBA 11/2016 - 09/2006
5	LigandsIBA 03/2013 - 04/2008
4	Therapeutic UsesIBA 12/2018 - 02/2013
4	DuxonIBA 09/2018 - 02/2013
4	HydrazonesIBA 01/2018 - 01/2014
4	Monoclonal AntibodiesIBA 03/2013 - 10/2003
3	AcidsIBA 02/2015 - 04/2004
3	Peptides (Polypeptides)IBA 03/2013 - 12/2005
3	OligopeptidesIBA 12/2012 - 12/2009
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2018 - 11/2015
2	XenonIBA 09/2018 - 11/2015
2	ProdrugsIBA 01/2018 - 01/2014
2	SolutionsIBA 01/2018 - 02/2013
2	AnthracyclinesIBA 10/2016 - 08/2011
2	Antineoplastic Agents (Antineoplastics)IBA 05/2016 - 12/2010
2	zinc protoporphyrinIBA 11/2015 - 02/2013
2	HydrazinesIBA 01/2014 - 12/2005
2	Liposomes (Liposome)IBA 01/2014 - 07/2009
2	CholesterolIBA 01/2013 - 08/2012
2	ErbB Receptors (EGF Receptor)IBA 12/2012 - 02/2008
2	BuffersIBA 09/2011 - 04/2011
2	DNA (Deoxyribonucleic Acid)IBA 08/2011 - 06/2011
2	AntigensIBA 11/2010 - 11/2009
2	Radioisotopes (Radionuclides)IBA 08/2010 - 10/2009
2	Immunoglobulins (Immunoglobulin)IBA 09/2007 - 08/2003
1	Dextran SulfateIBA 12/2018
1	anthraceneIBA 12/2018
1	AzoxymethaneIBA 12/2018
1	pyropheophorbide aIBA 09/2018
1	Photosensitizing Agents (Photosensitizers)IBA 09/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	Betulinic AcidIBA 11/2016
1	Protons (Proton)IBA 02/2016
1	CarcinogensIBA 11/2015
1	ellipticineIBA 02/2015
1	arginyl-glycyl-aspartic acidIBA 02/2014
1	NGR peptideIBA 02/2014
1	GlucocorticoidsIBA 01/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2014
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 12/2013
1	Singlet OxygenIBA 02/2013
1	bionoleIBA 01/2013
1	butyleneIBA 01/2013
1	liposomal doxorubicin (Doxil)FDA Link 03/2012
1	InterleukinsIBA 10/2011
1	Interleukin-12 (IL 12)IBA 10/2011
1	Carbonic Anhydrase IXIBA 10/2011
1	Immunoglobulin FragmentsIBA 10/2011
1	SuspensionsIBA 09/2011
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 09/2011
1	CytochromesIBA 09/2011
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2011
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 09/2011
1	Cytochrome P-450 CYP3AIBA 09/2011
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 09/2011
1	Cytochrome P-450 CYP2C8IBA 09/2011
1	Cytochrome P-450 CYP2C9IBA 09/2011
1	Cytochrome P-450 CYP2C19IBA 09/2011
1	AN 204 (AN 201)IBA 08/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 08/2011
1	Formaldehyde (Formol)FDA Link 08/2011
1	bacteriophage T7 RNA polymerase (T7 RNA polymerase)IBA 08/2011
1	Intercalating AgentsIBA 06/2011
1	EnzymesIBA 04/2011
1	Cathepsin BIBA 04/2011

Therapy/Procedure

21	Therapeutics 07/2019 - 05/2002
6	Drug Therapy (Chemotherapy) 12/2011 - 08/2003
3	Radiotherapy 02/2016 - 02/2007
2	Photochemotherapy (Photodynamic Therapy) 09/2018 - 11/2015
2	Intravenous Administration 11/2013 - 10/2010
1	Precision Medicine 09/2018
1	Endoscopes 09/2018
1	Combined Modality Therapy 02/2016
1	Microbubbles 11/2013
1	Aftercare (After-Treatment) 08/2013